Digital Health Application (Online Platform) for Encouraging Skills Practice for Attention Deficit Hyperactivity Disorder (ADHD)
This trial will create and refine an online platform to help clinicians treat adolescents with ADHD through behavioral and organizational skills interventions, with guidance from key stakeholders.
- Attention Deficit Hyperactivity Disorder (ADHD)
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
Is the age limit for participation in this trial under 55 years old?
"This clinical trial has specified that participants must be between 11 and 14 years old. 339 studies are recruiting for patients younger than 18, while 651 trials cater to those above the age of 65."
Are there particular criteria for qualifying to partake in this trial?
"This trial is looking to enrol 60 individuals who demonstrate Attention Deficit Hyperactivity Disorder - Inattentive type and are 11-14 years of age."
Is utilization of the Digital Health Application a secure way to build skills?
"Our team at Power assigned a score of 1 to the Digital Health Application (Online Platform) for Encouraging Skills Practice, due to it being in Phase 1 clinical trials with limited evidence supporting efficacy and safety."
Is recruitment still open for participation in this research project?
"According to clinicaltrials.gov, this investigation is currently enrolling participants; it was initially published on February 3rd 2021 and the details were last revised on October 19th 2021."
How many participants have enrolled in this research trial?
"Affirmative, according to information published on clinicaltrials.gov, the trial is actively enrolling patients at this present moment. It was first uploaded in February 2021 and updated last month. In total, 60 participants need to be recruited from a single medical centre."